首页> Cancer discovery> Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial.

Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial.

导出 OA

翻译打印收藏纠错

第一作者： Suzanne,Carreira

第一单位： The Institute of Cancer Research, London, United Kingdom.

作者： Suzanne,Carreira ^[1] ; Nuria,Porta ^[1] ; Sara,Arce-Gallego ^[2] ; George,Seed ^[1] ; Alba,Llop-Guevara ^[2] ; Diletta,Bianchini ^[3] ; Pasquale,Rescigno ^[3] ; Alec,Paschalis ^[3] ; Claudia,Bertan ^[1] ; Chloe,Baker ^[1] ; Jane,Goodall ^[1] ; Susana,Miranda ^[1] ; Ruth,Riisnaes ^[1] ; Ines,Figueiredo ^[1] ; Ana,Ferreira ^[1] ; Rita,Pereira ^[1] ; Mateus,Crespo ^[1] ; Bora,Gurel ^[1] ; Daniel,Nava Rodrigues ^[1] ; Stephen J,Pettitt ^[1] ; Wei,Yuan ^[1] ; Violeta,Serra ^[2] ; Jan,Rekowski ^[1] ; Christopher J,Lord ^[1] ; Emma,Hall ^[1] ; Joaquin,Mateo ^[4] ; Johann S,de Bono ^[5]

作者单位： The Institute of Cancer Research, London, United Kingdom. ^[1] Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain. ^[2] The Institute of Cancer Research, London, United Kingdom.;The Royal Marsden NHS Foundation Trust, London, United Kingdom. ^[3] The Institute of Cancer Research, London, United Kingdom. johann.debono@icr.ac.uk jmateo@vhio.net.;Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.;The Royal Marsden NHS Foundation Trust, London, United Kingdom. ^[4] The Institute of Cancer Research, London, United Kingdom. johann.debono@icr.ac.uk jmateo@vhio.net.;The Royal Marsden NHS Foundation Trust, London, United Kingdom. ^[5]

医学主题词抗肿瘤药(Antineoplastic Agents);DNA修复(DNA Repair);人类(Humans);男(雄)性(Male);前列腺肿瘤(Prostatic Neoplasms)

DOI 10.1158/2159-8290.CD-21-0007

PMID 34045297

发布时间 2025-05-30

基金项目